文献速递慢性肾脏病肾小球疾病

白蛋白尿与估算肾小球滤过率对静脉血栓栓塞风险的影响

Risk of Venous Thromboembolism in Patients by Albuminuria and Estimated GFR.
PubMed 文献 · Am J Kidney Dis · 2017-08-18

这项基于加拿大安大略省694,956名成人的人群队列研究(2002-2012)发现,白蛋白尿和eGFR均独立关联静脉血栓栓塞(VTE)风险,且白蛋白尿与VTE的关联因eGFR水平而异(交互作用P<0.001)。在eGFR正常(>90mL/min/1.73m2)者中,重度白蛋白尿(ACR>300mg/g)较无白蛋白尿者VTE风险高61%(sHR 1.61,95%CI 1.38-1.89);而在eGFR 15-29mL/min/1.73m2者中,无论白蛋白尿水平,VTE风险仅轻微增加。

要点

  • 白蛋白尿和eGFR均独立关联VTE风险,但两者存在显著交互作用。
  • eGFR正常伴重度白蛋白尿者VTE风险较无白蛋白尿者高61%。
  • eGFR 15-29mL/min/1.73m2者VTE风险仅轻微增加,与白蛋白尿水平无关。

核心结论

  • 白蛋白尿在eGFR正常患者中显著增加VTE风险,而在eGFR较低患者中增加幅度较小。

研究设计与样本

  • 基于人群的队列研究,纳入加拿大安大略省2002至2012年694,956名成人。

主要发现

  • 研究期间共发生15,180例(2.2%)VTE事件。
  • 白蛋白尿与VTE的关联因eGFR水平而异(ACR×eGFR交互作用P<0.001)。
  • eGFR>90mL/min/1.73m2且ACR>300mg/g者较eGFR正常无白蛋白尿者VTE风险高61%(sHR 1.61,95%CI 1.38-1.89)。
  • eGFR 15-29mL/min/1.73m2者中,ACR<30mg/g的sHR为1.23(95%CI 1-1.5),ACR>300mg/g的sHR为1.09(95%CI 0.82-1.45)。

临床怎么用

  • 对eGFR正常但存在重度白蛋白尿的患者,应关注VTE风险。

局限性

  • 仅使用单次ACR和eGFR测定。
  • VTE定义基于诊断/ICD编码。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The risk for venous thromboembolism (VTE) is elevated with albuminuria or a low estimated glomerular filtration rate (eGFR). However, the VTE risk due to the combined effects of eGFR and albuminuria are unknown. STUDY DESIGN: Population-based cohort study. SETTINGS & PARTICIPANTS: 694,956 adults in Ontario, Canada, from 2002 to 2012. FACTORS: eGFR and albumin-creatinine ratio (ACR). OUTCOME: VTE. RESULTS: 15,180 (2.2%) VTE events occurred during the study period. Both albuminuria and eGFR were independently associated with VTE. The association of albuminuria and VTE differed by level of eGFR (P for ACR × eGFR interaction < 0.001). After considering the competing risk for death, there was a 61% higher rate of VTE in patients with normal eGFRs (eGFRs>90mL/min/1.73m2) and heavy albuminuria (ACR>300mg/g) compared with those with normal eGFRs and no albuminuria (subdistribution HR, 1.61; 95% CI, 1.38-1.89). Among those with reduced kidney function (eGFR, 15-29mL/min/1.73m2), the risk for VTE was only minimally increased, irrespective of albuminuria (subdistribution HRs of 1.23 [95% CI, 1-1.5] and 1.09 [95% CI, 0.82-1.45] for ACR<30 and >300mg/g, respectively). LIMITATIONS: Only single determinations of ACR and eGFR were used. Diagnostic/International Classification of Diseases codes were used to define VTE. CONCLUSIONS: Albuminuria increases the risk for VTE markedly in patients with normal eGFRs compared with those with lower eGFRs.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Massicotte-Azarniouch D, Bader Eddeen A, Lazo-Langner A, et al. Risk of Venous Thromboembolism in Patients by Albuminuria and Estimated GFR. Am J Kidney Dis. 2017. PMID: 28823585. doi:10.1053/j.ajkd.2017.07.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。